683 Capital Management »

Calidi Biotherap shares owned by 683 Capital Management

Quarter-by-quarter ownership of Calidi Biotherap (CLDI) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Calidi Biotherap

Tip: Access up to 7 years of quarterly data

All positions including Calidi Biotherap held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Calidi Biotherap by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.3k 3.8k 1.14

More positions owned by 683 Capital Management

Eli Lilly & Co. Put Option (LLY)
Tesla Motors Put Option (TSLA)
Capital One Financial (COF)
Ero Copper Corp (ERO)
Hilton Grand Vacations (HGV)
Carvana Cl A (CVNA)
Insmed Note 0.750% 6/0 (Principal)
Wave Life Sciences SHS (WVE)
Alnylam Pharmaceuticals Put Option (ALNY)
Cogent Communications Hldgs Com New (CCOI)
Tg Therapeutics (TGTX)
BorgWarner (BWA)
Occidental Pete Corp *w Exp 08/03/202 (OXY.WS)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Viking Therapeutics (VKTX)

View all positions for 683 Capital Management

Top funds holding Calidi Biotherap

CPR Investments
Geode Capital Management
Susquehanna International
Delta Investment Management
Apollo Management Holdings
Evermay Wealth Management
Highbridge Capital Management
683 Capital Management
CVA Family Office
Householder Group Estate & Retirement Specialist
BlackRock
Advisor Group Holdings
Bank of America Corporation

View all funds holding Calidi Biotherap